Website: eurofinsgenomics.com   |   LinkedIn: linkedin.com/company/eurofinsgenomics

Genomics at Global Scale

How Eurofins Genomics delivers sequencing, genotyping, DNA synthesis, and bioinformatics to science and industry worldwide

At a glance

  • Company: Eurofins Genomics (eurofinsgenomics.com), the genomics division of the Eurofins Scientific Group
  • Headquarters: Ebersberg, Germany, with facilities across Europe, the United States, and Asia
  • Focus: DNA sequencing and genotyping services, DNA synthesis products, and bioinformatics
  • Markets: Pharma, diagnostics, population genomics, consumer genomics, academic research, and agrigenomics
  • Working with PSG on: Fractional commercialization services

The genomics engine of a global leader

Eurofins Genomics is part of Eurofins, one of the world’s largest bioanalytical testing networks. That scale gives customers something rare: the reliability and quality systems of a global organization, plus the breadth to handle everything from a single Sanger reaction to population-scale programs.

What Eurofins Genomics delivers

  • DNA sequencing: Sanger, next-generation, and long-read sequencing services
  • Genotyping: high-throughput array and sequencing-based genotyping for human, plant, and animal genomics
  • DNA synthesis: oligos, primers, probes, and genes
  • Bioinformatics: analysis and data services that turn raw data into results
  • Quality: ISO-accredited operations, including ISO 13485

Trusted for the biggest projects

Eurofins Genomics was selected to conduct genotyping for up to 5 million participants in Our Future Health, the UK’s largest-ever health research programme. In 2026 it acquired Weatherbys Scientific, strengthening its animal genomics offering and expanding into Ireland and Australia, and partnered with ADLIN Science to speed up the use of genomic data.